KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

LifeMD (LFMD) Net Margin (2016 - 2025)

Historic Net Margin for LifeMD (LFMD) over the last 14 years, with Q3 2025 value amounting to 7.62%.

  • LifeMD's Net Margin rose 25900.0% to 7.62% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.54%, marking a year-over-year increase of 74900.0%. This contributed to the annual value of 11.74% for FY2024, which is 38000.0% up from last year.
  • As of Q3 2025, LifeMD's Net Margin stood at 7.62%, which was up 25900.0% from 3.82% recorded in Q2 2025.
  • In the past 5 years, LifeMD's Net Margin registered a high of 1.5% during Q1 2025, and its lowest value of 75.43% during Q2 2021.
  • Its 5-year average for Net Margin is 29.41%, with a median of 17.87% in 2023.
  • Within the past 5 years, the most significant YoY rise in LifeMD's Net Margin was 1808900bps (2021), while the steepest drop was -382500bps (2021).
  • Quarter analysis of 5 years shows LifeMD's Net Margin stood at 69.24% in 2021, then soared by 35bps to 45.21% in 2022, then surged by 78bps to 10.05% in 2023, then increased by 4bps to 9.61% in 2024, then increased by 21bps to 7.62% in 2025.
  • Its Net Margin stands at 7.62% for Q3 2025, versus 3.82% for Q2 2025 and 1.5% for Q1 2025.